Morphine Kalceks (Morphine Hydrochloride Trihydrate)

Morphine, an opioid analgesic, is used for moderate to severe pain management across several clinical settings.

• Acute severe pain: delivers rapid analgesia for trauma, burns or surgical emergencies.
• Postoperative pain: controls pain after major surgical procedures.
• Cancer pain: provides sustained relief for malignant disease‑related pain.
• Chronic severe pain: used when other analgesics are inadequate or not tolerated.

• Morphine acts as a full agonist at mu‑opioid receptors in the central nervous system. Binding inhibits adenylate cyclase activity, reduces calcium influx and increases potassium efflux, which suppresses the transmission of nociceptive signals in the spinal cord and alters pain perception in the brain, resulting in analgesia.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea and vomiting
• Constipation
• Drowsiness or sedation
• Dizziness or light‑headedness
• Sweating
• Itching or pruritus

Serious or Rare Side Effects

• Respiratory depression
• Severe hypotension
• Opioid dependence or addiction
• Adrenal insufficiency
• Anaphylactic or severe allergic reaction
• Serotonin syndrome (when combined with serotonergic agents)

When using Morphine Kalceks, clinicians should observe specific safety measures.

• Assess pain severity: confirm that opioid therapy is appropriate for the level of pain.
• Monitor respiratory function: watch for signs of respiratory depression, especially after dose initiation or escalation.
• Evaluate organ function: adjust dosing in patients with hepatic or renal impairment.
• Use caution in the elderly: start with lower doses and titrate slowly.
• Avoid concurrent CNS depressants: limit use with benzodiazepines, barbiturates or alcohol.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Morphine can interact with several drug classes, influencing its safety and efficacy.

Major Interactions (Avoid)

• Other opioids: increased risk of respiratory depression.
• Central nervous system depressants (e.g., benzodiazepines, barbiturates): additive sedation.
• Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.
• Alcohol: potentiates CNS depression.
• Respiratory depressants (e.g., anesthetic gases): severe respiratory compromise.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise morphine levels.

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy.
• Diuretics: can enhance hypotensive effects.
• Antihistamines: may increase sedation.
• Selective serotonin reuptake inhibitors (SSRIs): monitor for serotonin syndrome.